Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Lilly and EVA Pharma partner to improve insulin access in Africa

By Brian Buntz | December 15, 2022

EVA Pharma/LillyEli Lilly and Company (NYSE: LLY) and Egypt-headquartered EVA Pharma have developed a plan to collaborate to supply at least one million people in low- and middle-income countries. Many of the recipients of the vaccines will be in Africa. 

Roughly a month ago, Lilly’s share price fell about 4% after a fake Twitter account stated the company would make insulin available at no cost. 

Following that event, Public Citizen and more than 50 other organizations contacted congressional leaders asking for legislation that guarantees more-affordable insulin pricing in the U.S.

Lilly and other insulin providers have faced criticism over pricing. 

As part of its environmental, social and corporate governance (ESG) focus, the company has a program known as the Lilly 30×30 initiative, which intends to improve access to quality healthcare for 30 million people in limited-resource settings each year by 2030.

Lilly noted in a press release that the deal with EVA Pharma is the first time it has agreed to provide its active pharmaceutical ingredient (API) for insulin at “a significantly reduced price.” 

The company will also offer a pro-bono technology transfer to the company to help it formulate, fill and finish insulin vials and cartridges. 

EVA Pharma anticipates that it will begin distributing insulin in the next 19 months. It plans to provide insulin to one million people annually by 2030. 

The state of California also has announced a plan to reduce the cost of insulin by enlisting a contract manufacturer. In November, reports suggested that the state was planning to work with the nonprofit generic drug company Civica Rx to produce the hormone.

EVA Pharma has also emerged as a leading African supplier of medicines for HIV/AIDS in recent years, reducing the continent’s reliance on imports to fight infections from the virus. A recent article in AhramOnline noted that Egypt can now provide treatment for 97% of Africans living with HIV/AIDS. 

The company also produces the COVID-19 antivirals molnupiravir and remdesivir. In 2021, EVA Pharma announced that it had signed a deal with India to supply 300,000 doses of the latter antiviral. 

EVA Pharma was founded in 1997.  

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE